BWIN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Baldwin Insurance Group Inc (BWIN) shows mixed signals for a beginner, long-term investor. While the stock has seen a significant price increase recently, the technical indicators and financial performance suggest caution. The lack of strong proprietary trading signals and the absence of clear positive catalysts make this stock less compelling as a buy right now. Holding the stock or waiting for further clarity on its financial and market performance is advised.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 67.795, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance levels (R1: 18.214, R2: 18.87), suggesting limited immediate upside potential.
Hedge funds are significantly increasing their positions, with a 684.07% rise in buying activity over the last quarter. Analysts have highlighted potential for high single-digit organic revenue growth in 2026, driven by synergies from the CAC Group merger and a robust distribution network.
The stock has underperformed recently, and concerns about AI displacement in the insurance sector have weighed on sentiment. Analyst price targets have been lowered by some firms, and the company's financials show a net loss despite YoY improvement.
In Q3 2025, revenue increased by 1.74% YoY to $93.25M, and net income improved by 123.55% YoY but remains negative at -$18.73M. EPS also improved by 107.69% YoY to -0.27, but gross margin remains at 0%.
Analyst ratings are mixed. TD Cowen initiated a Buy rating with a $37 price target, citing growth potential and synergies. However, Raymond James and JPMorgan have lowered their price targets to $20 and $28, respectively, citing challenges in the P&C insurance sector. Wells Fargo upgraded the stock to Equal Weight from Underweight, citing valuation as a floor.
